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A circulatory arrest model in the rat was developed for use in cerebral and cardiac resuscitation 
studies. Whole-body ischemia was produced for 8 to 18 minutes by arresting the heart with a 
cold potassium chloride cardioplegic solution. Following cardiopulmonary resuscitation, 
minimal, standardized intensive care was provided. As the duration of ischemia was increased 
from 8 to 18 minutes, survival immediately following resuscitation decreased from 100% to 
25%, and survival at 48 hours after ischemia decreased from 80% to 0%. Thirty per cent of the 
rats recovering from 11 minutes of ischemia suffered motor seizures. Survival and the incidence 
of motor seizures appear to be good measures of outcome following ischemic circulatory arrest. 
These measures can be used to test the possible anti-ischemic actions of calcium antagonists or 
other drugs. 
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Between 10% and 40% of people who survive out of hospital circulatory arrest experience 
significant neurological damage [1]. Some of the damage caused by ischemic anoxia occurs after 
reperfusion and is amenable to therapy [2]. Intense effort is under way to discover drug therapies 
that attenuate postischemic encephalopathy, even though the drugs would be given after the 
period of ischemia--that is, after cardiopulmonary resuscitation (CPR) and restoration of 
circulation. Such research requires efficient, reproducible, and, if possible, low cost animal 
models. 
 
Animal models previously described in cerebral resuscitation studies employ dogs or monkeys as 
subjects [3-5]. The canine model developed by Safar et al. [3] is created by inducing 12 minutes 
of unsupported ventricular fibrillation, from which as many as 67% (23/ 34) of the dogs are 
never resuscitated and therefore do not enter into the cerebral resuscitation phase of the study. 
Bleyaert and co-workers [5] have developed a high-pressure neck tourniquet model in the 
monkey. In this model, whole-body ischemia was avoided in order to minimize problems with 
extracranial complications. Still, 25 of 62 animals could not be included in the final results, 
owing to various experimental difficulties. Such loss of expensive laboratory animals is 
inefficient and costly, and has encouraged several groups to consider small animal models. In 
this study we present the development and characterization of a circulatory arrest model in the 
rat, which can be used to evaluate the effects of cerebral resuscitation measures such as treatment 
with calcium antagonists or barbiturates. 
 
 
MATERIALS AND METHODS 
 
Rat Circulatory Arrest Model 
 
Male Wistar rats were used in all studies. Before experimentation, they were housed in a 12-hour 
light-dark cycle that started at 6:00 AM. Food and water were provided ad libitum. 
 
Ketamine was used as the anesthetic agent because it has lesser effects on the cardiovascular 
system and plasma catecholamine levels than other agents [6] and because, unlike barbiturates 
[7], it is not thought to block membrane calcium channels. Each rat was ventilated by use of 
pressure-limited jet ventilation via a 16-gauge Teflon
®
 cannula inserted through a midline 
tracheostomy. Tidal volume during artificial ventilation ranged from 2 to 5 ml. A 2-mm 
diameter, soft rubber stomach tube was placed to release trapped gases from the stomach. 
Succinycholine (1.5 mg/kg) was administered intraperitoneally 5 minutes before the arrest to 
block gasping, which in itself can create blood flow during cardiac arrest [8]. A heat lamp was 
used to maintain rectal temperature between 36 and 38 °C during the prearrest and postarrest 
phases. During the circulatory arrest the rat was allowed to cool, as would usually occur in 
clinical cardiac arrest. 
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The four major phases of the protocol are illustrated in Figure 1. They are the arrest, 
resuscitation, intensive care, and survival phases. The specific steps taken in each phase are 
listed in Table 1. In phase I, cardiopulmonary arrest was accomplished in 94 rats ranging in body 
weight from 350 to 450 grams by cessation of jet ventilation and injection of 0.4 to 0.8 ml of a 
cold 1% KCl cardioplegic solution percutaneously into the left ventricle of the heart.  
 
Initially, a 0.4 ml bolus of KCl was injected rapidly into the left ventricle of the heart. If within 
the first 30 seconds of the arrest an apex beat was detected, additional 0.2-ml volumes of KCl 
were injected, up to a total of 0.8 ml. In approximately half the animals, a weak apex beat 
returned after KCl injection and cessation of ventilation, and gentle thoracic pressure (“chest 
restriction”) was applied transthoracically with two fingers at the level of the heart. Such chest 
restriction caused disappearance of pulses within a few seconds and aborted spontaneous 
recovery from the arrest. Arrest was verified by the absence of a palpable apex beat. The arrest 
was allowed to continue for a predetermined number of minutes, after which time attempts were 





FIGURE 1. The four major phases of the rat circulatory arrest model. The preparatory 
phase is followed by phase I, potassium-induced cardiac arrest; phase II, 
cardiopulmonary resuscitation; phase III, minimal intensive care; and phase IV, 
survival and qualitative assessment of neurological outcome. The time line shows 













Interposed abdominal compression-CPR (IAC-CPR) [9] and jet ventilation (frequency 70/min) 
were used to resuscitate the rats. The IAC-CPR was performed as follows: two fingers of one 
hand were placed midline on the sternum halfway between the xyphoid and the manubrium so 
that the heart was directly compressed, and three fingers of the other hand were placed on the 
lower abdomen to perform the abdominal compressions. Thoracic compressions were 
simultaneous with expiration, and abdominal compressions were interposed between thoracic 
compressions. Palpation of an apex beat was used to establish return of the circulation. The 
duration of ischemia was measured from the onset of the sudden drop in blood pressure or the 
loss of an apex beat to the restoration of a pulse pressure or apex beat. 
 
In phase III, minimal and uniform intensive care was supplied to each rat. Approximately 5 
minutes after resuscitation, jet ventilation was reduced to 40/min. Thirty minutes after ischemia, 
5 ml each of a 5% dextrose solution and a lactated Ringer’s solution were injected 
subcutaneously to maintain hydration. The rats were placed on a 37 °C heating pad, and artificial 
ventilation was continued at a rate of 40/min until vigorous spontaneous respirations were 
observed. At this time the tracheal tubes were removed from the rats, their neck wounds sutured, 
and the animals returned to individual cages. In phase IV, survival and qualitative neurological 
outcome were monitored. 
 
Confirmation of Circulation Arrest 
 
To establish that palpation of the apex beat transcutaneously was a reliable method of monitoring 
cardiac mechanical activity, we conducted a study in 15 rats to verify circulatory arrest. The 
animals underwent arrest with KCl injection as described, and carotid arterial blood pressure was 
monitored with a disposable pressure transducer (Cobe Laboratories, Inc., Lakewood, Colorado). 
The presence or absence of an apex beat as determined by the experimenter was compared in 
time to arterial pressure recordings. In the subsequent survival study, cardiac arrest was 
confirmed only by disappearance of the palpable apex beat to minimize the amount of surgical 
trauma and to avoid ligating a carotid artery. 
 
Characterization of the Model: Survival Study 
 
To characterize this rat circulatory arrest model, a survival study was conducted without drug 
intervention. In this study 79 rats were subjected to an ischemic insult (6 to 12 minutes of total 
circulatory arrest followed by IAC-CPR as previously described), and survival was monitored 





Confirmation of Circulatory Arrest  
 
Illustrated in Figure 2 is a typical record of one of the 15 rats in which blood pressure was 
measured to verify circulatory arrest. Immediately after KCl injection, arterial blood pressure fell 
promptly to about 20 mm Hg without pulsations. Injection of KCl produced an 
electromechanical dissociation. After 9 minutes of circulatory arrest, IAC-CPR was begun. In 
this rat the circulation returned spontaneously after 1 minute, 40 seconds of IAC-CPR. The 
palpable apex beat was correlated in time to the graphic record, showing recovery of pulsatile 




FIGURE 2. Physiograph record of the arrest and resuscitation of a rat. Channels 1 
and 2 illustrate carotid blood pressure and electrocardiogram, respectively. At t = 0 
min, 0.4 ml cold KCl was injected percutaneously into the left ventricle of the heart, 
causing a rapid drop in blood pressure. An additional 0.2 ml was injected to ensure 
continued arrest of the heart. At t = 9 min, artificial ventilation was resumed and a 
series of deep ventilations (sighs) were given before cardiopulmonary resuscitation 
(CPR) was begun. The pulsatile pressure waveform and elevated diastolic pressure 
illustrate the effectiveness of IAC-CPR in rats. Approximately 1 minute, 40 seconds of 
CPR elapsed before the rat’s heart spontaneously recovered and a palpable apex beat 
was detected. Palpation of the apex beat correlated well in time with the presence of 
arterial pressure pulses in the carotid artery. 
 
 
In none of the 15 rats was a palpable apex beat detected when arterial pressure pulses were 
absent. We did not detect an apex beat by palpation when pressure pulses of 10 mm Hg were 
present in a single rat. In all the 15 rats in which we monitored carotid blood pressure, we were 
able to abruptly arrest the heart as indicated by a drop in arterial blood pressure to 20 mm Hg or 
less. Within the first 2 minutes of arrest there were sporadic pressure pulses in eight of the 15 
rats, but these were no greater than 20 mm Hg in amplitude. As shown in Figure 3, chest 
restriction and additional doses of KCl aborted the spontaneous recovery of the arrested heart. 
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The effectiveness of chest restriction alone in preventing cardiac pumping in the rat is clearly 
illustrated in Figure 4. The combination of KCl injection and chest restriction successfully 
produced controlled circulatory arrest in 15 of 15 rats. Having completed this preliminary study 
in the 15 rats, we felt confident in monitoring cardiac mechanical activity solely by palpation of 
the apex beat. 
 
FIGURE 3. Spontaneous recovery of a rat heart shortly after the initial arrest. 
Additional ECG doses of KCl were injected, and chest restriction was applied. The 




FIGURE 4. The effect of chest restriction on arterial blood pressure in a normally 
beating rat heart. Approximately 20 mm Hg of pressure was applied transthoracically 
with thumb and index finger at the level of the heart, causing arterial blood pressure to 
fall to a minimum of 25 mm Hg. The highly compliant rat chest and small size of the 




For all the durations of ischemia tested, 33% (26/79) of the rats were not resuscitated. Of those 
rats not resuscitated, 50% (13/26) were observed to have thoracic damage upon gross 
postmortem examination because of experimental difficulties. 
 
The results of the survival study are recorded as percentage of rats resuscitated and percentage of 
the total rats alive 48 hours after ischemia (Fig. 5). The results are presented with respect to the 
total duration of ischemia, which is defined as the time to definitive therapy and is equal to the 
arrest time plus the CPR time. After 8 minutes of ischemia, a pulse was restored in 100% of the 
rats, and 60% of all rats were alive 48 hours after ischemia. After 18 minutes of ischemia, 25% 
of rats were resuscitated and 0% were alive at 48 hours. For the intermediate durations of 
ischemia, the resuscitation and survival rates decreased linearly. The resuscitation and survival 
rates were statistically different (P  0.05) between the 8-minute and 18-minute durations of 
ischemia, according to Fisher’s exact test. Although statistical significance was not observed 




FIGURE 5. Percentage of resuscitation and survival as a function of the total duration 
of ischemia. Open bars represent the percentage of rats resuscitated, as demonstrated 
by restoration of pulse. Shaded bars represent the percentage of rats in each group that 
were alive 48 hours after ischemia. The ratios above each bar reflect the absolute 





This ischemia rat model produced high incidence of motor seizures following arrest and 
resuscitation. These seizures were characterized by the rat’s running rapidly in the cage for 
approximately 1/2 to 2 minutes. Seizures would end when the rat collapsed into a flaccid state 
suggestive of postictal depression. In some cases presumably more severe, the seizures 
progressed into a tonic-clonic stage characterized by opisthotonus. These animals also showed 
signs of severe postical depression. The number of rats suffering seizures for each duration of 
ischemia is shown in Figure 6. At 8, 15.5, and 18 minutes of ischemia there were no seizures. 





FIGURE 6. Percentage of total number of rats at each duration of ischemia having 
motor seizure activity in the 48 hours after ischemia. No rats had seizures at the 
extreme durations of ischemia. but a maximum of 30% (5/17) of the rats surviving 11 





In the survival study presented here, we have measured the resuscitation, survival rates, and 
occurrence of seizure activity with whole-body ischemia ranging from 8 to 18 minutes. The 
results suggest that an efficient duration of ischemia for drug intervention studies would be 11 
minutes. At this duration there was a resuscitation rate of at least 80% and approximately 40% 
survival 48 hours after ischemia. The high resuscitation rate makes the model efficient, since 
only one in five rats failed to enter into the cerebral resuscitation phase of the study. With a 40% 
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survival rate at 48 hours, it should be possible to detect changes in survival and seizure activity 
in drug-treated rats compared with controls. 
 
The previously unreported observation of motor seizures in resuscitated rats has proved to be a 
simple, objective measure of cerebral dysfunction. We believe, as does Edmeads [10] that three 
cell populations exist in the brain following an ischemia insult: 1) healthy neurons and neuroglia 
that survive the insult unharmed, 2) cells that die outright from the insult, and 3) cells that are 
damaged and may either survive or die depending on the course of therapy. These damaged cells 
of the brain are the focus of aggressive cerebral resuscitation efforts. The damaged neurons 
probably function as foci of the CNS seizure activity. Thus, the seizure activity we have 
observed probably reflects the presence of damaged neurons in the brain. Accordingly, 
interventions that both improve survival and diminish seizure activity in this model hold promise 
for clinical application in attenuation of postischemic encephalopathy. 
 
All animal and human studies of brain resuscitation face four fundamental problems that make 
interpretation of results difficult:  
 
First, complete cerebral ischemia must be verified. Neck tourniquet models do not generally 
occlude the vertebral arteries, protected in their bony canals. Models requiring surgical ligation 
of the carotid and vertebral arteries are at the mercy of variable degrees of collateral circulation 
via the spinal and subclavian arteries. In models such as the present one using cardioplegia 
solution, the heart may escape control and begin beating normally. Only documented ventricular 
fibrillation produces certain circulatory arrest, but this arrhythmia is not reliably sustained in 
small animals [11]. 
 
Second, cardiac resuscitation from whole-body ischemia severe enough to create significant 
brain dysfunction is extremely difficult. Hendrickx et al. [12] have developed a rat circulatory 
arrest model in which they create total circulatory arrest by asphyxiation. In this model, cardiac 
mechanical activity persists during a portion of the asphyxia time. Hermans and co workers [11] 
create circulatory arrest by such rapid cardiac electrical stimulation that the rats are in a state of 
pseudo-fibrillation. There are major differences from our model and theirs. Normothermic 
cardiac ischemia with fibrillation or continuous cardiac mechanical activity (as in the early 
stages of asphyxia) results in greater myocardial oxygen demand and debt than in a hypothermic, 
potassium-arrested heart [13, 14]. High-energy phosphate levels in the myocardium of isolated 
rat hearts were determined to be at least twice as great in a normothermic potassium-arrested 
heart than in a normothermic fibrillating heart [15]. Myocardial ischemia following either 
asphyxia or fibrillation may limit the duration of whole-body ischemia from which the rat can be 
resuscitated. The duration of insult may therefore be too short to create significant cerebral 
damage. We arrest the heart with a cold potassium cardioplegic solution and can achieve survival 
at longer durations of whole-body ischemia, thereby producing significant cerebral dysfunction. 
This provides a suitable pathological substrate for testing therapeutic interventions. 
 
Third, outcome is often influenced by extracranial complications, such as pulmonary edema, 
sepsis, and cardiogenic shock. Each of these conditions can produce deterioration of neurological 
status that is unrelated to both the primary ischemic-anoxic event and the experimental therapy 
directed toward it. Such extracranial complications have produced major experimental 
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difficulties in the monkey model of Bleyaert et al. [5] and in the studies of White et al. [4] as 
well, requiring extensive staffing and expense to keep the animals alive. Extracranial 
complications do not appear to be a major complication in our model. Pulmonary edema and 
sepsis were not seen with regularity in the arrested rats we studied. Since arrest can be monitored 
by palpation, only a single incision is required for the tracheal cannula, and this has not been the 
site of complications. (In early studies to show circulatory arrest with an intravascular cannula, 
leg edema and gangrene did follow femoral artery catheterization.) 
 
Fourth, intensive care procedures vary during the postischemic phase. To survive to a stage of 
stable neurological deficit, large animals and human beings require more elaborate intensive 
care, including mechanical ventilation, fluids, pressor drugs, antibiotics, and inotropic agents. If 
these therapies are individualized, as in clinical practice, experimental and control subjects are 
not strictly comparable, and the validity of the study is compromised. Intensive care measures in 





We believe this model provides satisfactory circulatory arrest for cerebral resuscitation studies. 
Although the ventricles sometimes escape from the influence of intracardiac KCl, the addition of 
gentle chest restriction appears to abort the return of circulation by limiting cardiac filling and/or 
emptying in small animals, such as rats, with compliant chest walls. In this way, circulatory 
arrest is produced reliably without surgery. We also believe that the proposed circulatory arrest 
model is simple, easy to replicate in other laboratories, and capable of generating statistically 
significant survival data with large numbers of subjects at reasonable cost and effort. Moreover, 
this method could be useful in screening the large numbers of compounds potentially beneficial 
in ameliorating permanent disability following cardiac arrest and CPR. 
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